coact.ca

What It Is

Coact Technologies is a remote ultrasound technology company from Canada. Its goal is to help rural, remote, and Indigenous communities access specialist-level ultrasound exams without requiring patients to travel long distances for referrals. Its solution is not simply video guidance, nor is it a full robotic system. Instead, it combines mixed reality, remote control, haptic feedback, and high-speed communication so that a remote physician can guide a local novice in moving a real ultrasound probe “as if they were on site.”

Core Capabilities

On the patient side, the product consists of a mixed reality headset, a real ultrasound probe, position/orientation/force sensors, and a tablet. On the expert side, the physician uses a haptic input device similar to an ultrasound probe handle to control a virtual probe. The novice aligns the real probe with the virtual probe, while the expert can view real-time video and ultrasound images, communicate via two-way voice, and gain an immersive operating experience through 6-DoF input and force feedback. The website also mentions patient-specific modeling, feedback, and AI assistance, but it does not specify the type of AI model, automated diagnostic capabilities, or validation metrics. As such, it should not be regarded as a mature AI diagnostic tool.

Pricing and Integration

The website includes a “Subscribe” option, suggesting that it may use a subscription model, but it does not disclose pricing, plans, free trials, hardware costs, or payment methods. In terms of integration, the site emphasizes security, end-to-end encryption, low-latency peer-to-peer cloud connections, transmission of video and ultrasound streams, and device-agnostic remote control of ultrasound machine settings. However, it does not publish an API or SDK, nor does it explain integration capabilities with medical systems such as PACS, HIS, or EMR.

Pros and Cons

Its strengths lie in a clearly defined use case: the technical approach sits between low-cost video guidance and expensive robotic systems, balancing mobility, fine control, and a feedback-rich experience. It also has roots in UBC’s robotics and control lab, with support from multiple papers, patents, and awards. The main weakness is the lack of information on commercial maturity: regulatory approvals, large-scale clinical results, supported exam types, after-sales support, and deployment costs are not clearly disclosed. The AI-related descriptions are also relatively general.

Who It’s For and Access from China

It is better suited to remote healthcare providers, public health authorities, ultrasound specialist networks, research hospitals, and clinical pilot projects rather than individual consumers. The website does not provide information about access from China. Payment, Chinese-language support, compliance implementation, and local after-sales service are all unclear. For deployment in China, particular attention would need to be paid to medical device registration, cross-border data handling, low-latency network requirements, and local alternatives.